Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bone marrow derived mesenchymal stem cells (3 trials)
Amyotrophic Lateral Sclerosis (Phase 2)
Intervertebral Disc Degeneration (Phase 2)
Motor Neuron Disease (Phase 2)
Rotator Cuff Injuries (Phase 2)
Sclerosis (Phase 2)
Trials (3 total)
Trial APIs (1 total)